Leadership

Our team has extensive experience in the medical device and biosensor industries.

Executive Management

John Alberico

President and Chief Executive Officer

John was the Managing Director of the Inverness Medical Limited (“Inverness”) subsidiary in Scotland, which manufactured the company’s glucose testing strips. During his 21-month tenure, he spearheaded efforts to increase the operation’s efficiency, building the capacity to cost-effectively produce over 1 billion test strips annually. He was also responsible for transferring the manufacturing of the company’s meter products to China.

Prior to Inverness, John was the Vice President of Operations for Bionostics Inc., a medical reagents and controls company, and the Vice President of Manufacturing for Nova Biomedical, a medical instrumentation company. John is also the founder of Medical Devices, Inc., an engineering consulting company specializing in the offshore contract manufacturing of high volume consumer medical devices. He holds a bachelor’s degree in biomedical engineering from Boston University.

Jackson McAdam

Chief Financial Officer

Since joining AgaMatrix in 2014, Jackson has steadily moved from his initial director’s role to the company’s most senior financial professional. A key participant in the company’s recent strategic efforts, Jackson was integral in the acquisition of the CGM platform from iSense CGM, Inc. and Bayer Healthcare in early 2016, as well as the financing and tax reorganization efforts leading to the recent Prospect Capital deal for $32 million.

Prior to joining AgaMatrix, Jackson spent a total of nine years with Kronos Incorporated, a private equity owned software and service organization reporting $1 billion in annual revenues, where he held various senior finance positions. Jackson also served as Director of Internal Audit with a supply chain management services company, Moduslink Global for three years and began his career with PricewaterhouseCoopers. He holds a bachelor’s degree in accounting from Bentley College.

Chuck Johnson

Vice President of Engineering

A veteran technical manager, Chuck joined AgaMatrix in 2011 and has since held a senior leadership role for the company’s engineering development activities. Chuck has been a key contributor to the company’s product portfolio from the first FDA-cleared blood glucose monitor to connect directly to the iPhone, iBGStar to our latest Jazz Wireless 2 meter. Chuck’s nearly 40 years of engineering experience has involved a number of successful roles in the medical device industry, including Director of Engineering at Eleme Medical (acquired by Cynosure) where he oversaw the development of systems to treat kidney stones, vascular lesions, wrinkles, cellulite, tattoo removal and removal of unwanted hair. He was also Vice President, Development Engineering at Candela Corporation where he was responsible for the development of the company’s variable pulse duration YAG Laser for hair removal which was the company’s most successful product.

Chuck earned his master’s degree in electrical engineering from Worcester Polytechnic Institute and his bachelor’s degree in electrical engineering from Manhattan College.

David Olsen

Vice President, Quality Assurance, Regulatory and Clinical Affairs

Dave joins AgaMatrix with 25 years of experience as a Regulatory Affairs and Quality professional in the IVD, medical devices, biotechnology and biologics environment. His extensive experience in new product development and licensure within the U.S., Canada, European Union, Brazil, India and China includes his most recent role at Harvard Apparatus Regenerative Technology, Inc., a Holliston, Massachusetts biotechnology company specializing in the development of cell-based tracheal prostatic. There, he worked as Director of Regulatory Affairs, Clinical Affairs and Quality Assurance.

Among his previous roles, Dave served as Vice President, Corporate Regulatory and Quality for five years at SeraCare Life Sciences, Inc., a $60 million IVD biotechnology company specializing in the manufacture of serological and nucleic acid controls and reference materials. Dave has also held executive and management positions with Defibtech, LLC, American Red Cross, and C.R. Bard, Inc. Dave earned his Juris Doctor degree from the Massachusetts School of Law, his bachelor’s degree in chemistry from Salem State University, and an LL.M. in banking and financial law at Boston University School of Law.

Cara Mottolo

Vice President of Human Resources

Cara has lead the organization’s human resources efforts since joining AgaMatrix late in 2010 and oversees all personnel activities for the company’s more than four hundred employees located in the United States, Hong Kong, China and the United Kingdom. A key participant in the company’s acquisitions, Cara has guided the personnel integration in 2014 of the meter factory in Dongguan, China as well as the 2016 CGM entity in Wilsonville, Oregon. Cara also serves as the the main point of contact for the company’s shareholders and employees regarding equity administration.

During Cara’s seventeen years in the human resources profession, she has lead efforts in a variety of industries from the medical device company NMT Medical, Inc. to the sports and entertainment venue the Boston Garden (at the time the FleetCenter). Much earlier in her professional career, Cara spent time in broadcast journalism with on air positions at several local radio stations. She holds a bachelor’s degree in communications from the University of Massachusetts, Amherst.

Board of Directors

John Alberico

Director, President and Chief Executive Officer

John was the Managing Director of the Inverness Medical Limited (“Inverness”) subsidiary in Scotland, which manufactured the company’s glucose testing strips. During his 21-month tenure, he spearheaded efforts to increase the operation’s efficiency, building the capacity to cost-effectively produce over 1 billion test strips annually. He was also responsible for transferring the manufacturing of the company’s meter products to China.

Prior to Inverness, John was the Vice President of Operations for Bionostics Inc., a medical reagents and controls company, and the Vice President of Manufacturing for Nova Biomedical, a medical instrumentation company. John is also the founder of Medical Devices, Inc., an engineering consulting company specializing in the offshore contract manufacturing of high volume consumer medical devices. He holds a bachelor’s degree in biomedical engineering from Boston University.

K. Thomas Bailey

Director

Tom joined the company as Chief Financial Officer in March 2014. Prior to joining AgaMatrix as CFO, Tom served as President and CEO for Angiotech Pharmaceuticals Inc. until the fall of 2013, at which time he transitioned to Angiotech’s board. As CEO of Angiotech, he led the company through a successful operational restructuring and concluded the sale of one of Angiotech’s two medical device products businesses, generating significant returns for shareholders. Prior to being named Angiotech’s CEO in the fall of 2011, Tom served for six years as Angiotech’s CFO and for two years as Vice President of Business Development. Prior to Angiotech, he worked as an investment banker in the life sciences practice group at Credit Suisse First Boston and Donaldson, Lufkin & Jenrette.

Tom currently serves as a member of the Board of Directors for Angiotech Pharmaceuticals, Inc. and LifeCare Management Services. He is a graduate of Harvard University and received his MBA from Harvard Business School.

Carlos A. Ferrer

Director

Carlos is a founding member of Ferrer Freeman & Company, LLC. Prior to creating FFC, he was a Managing Director at Credit Suisse First Boston. From 1982 through 1995, he developed and served as Head of CSFB’s Global Health Care Investment Banking Group. Carlos is Vice Chairman of the Board of Trustees of the Cancer Research Institute and a member of the Board of Directors of Ardent Health Services, LLC, GeneraMedix Pharmaceuticals Inc., OrthoRx, Inc., Preferred Care Partners Holding, Corp., and Viant Holdings, Inc. He graduated from Princeton University.

Dr. Paul Kelly

Director

Paul is Managing Director of Australian venture capital firm, OneVentures, and has held numerous executive positions in the biotechnology industry. He is currently Chair of Vaxxas Pty Ltd, Hatchtech Pty Ltd and non-executive director of Charm Health Pty Ltd.

Paul co-founded NASDAQ listed Gemini Genomics plc, which was acquired by Sequenom (Nasdaq: SQNM) in 2001 and led the restructuring of another listed US company, Orchid Cellmark (Nasdaq: ORCH), generating substantial returns and exits for investors. Paul led the seed financing of AgaMatrix in 2002 and co-founded Mears Technologies Inc, a Boston-based engineered materials company focused on the development and commercialization of products based on its proprietary electronic materials platform. In addition he has assisted and led a number of early-stage and mid stage companies in achieving business results in order to attract funding and transform their ideas, technologies, and products into sustainable and successful businesses.

Walter Winshall

Director

Walt is a principal in Collaborative Seed and Growth Partners, LLC, an investment firm specializing in the commercialization of early-stage technology. Previously, he was a co-founder and Chairman of SilverPlatter International, NV, a company providing information services for libraries, which was acquired by the Dutch publishing company Wolters Kluwer in 2001. He graduated from MIT in electrical engineering and from the Harvard Law School. At AgaMatrix, Walt provides guidance in corporate development strategy.

patents-emblem

Our proprietary science and designs are protected by 170 granted and 39 pending U.S. and international patents.